The C12 mutant of MHV-A59 is very weakly demyelinating and has five amino acid substitutions restricted to the spike and replicase genes

Advances in Experimental Medicine and Biology

Volumn 440, Issue , 1998, Pages 627-633

  Leparc Goffart, Isabelle ^a   Hingley, Susan T ^b   Jiang, Xinhe ^a   Chua, Ming Ming ^a   Lavi, Ehud ^c   Weiss, Susan R ^a  

^a PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b Department of Microbiology ^*

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED RNA POLYMERASE; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DEMYELINATING DISEASE; ENCEPHALITIS; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS MUTANT; VIRUS VIRULENCE;

ANIMALIA; CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS;

EID: 0031721073     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5331-1_81     Document Type: Article

References (17)

1. Adami, C., Pooley, J., Glomb, J., Stecker, E., Fazal, F., Fleming, J. O., and Baker, S. C., 1995, Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA, Virology 209: 337-346.
2. Bonilla, P. J., Gorbalenya, A. E., and Weiss, S. R., 1994, Mouse hepatitis virus strain A59 RNA polymerase gene ORF 1a: heterogeneity among MHV strains, Virology 198: 736-740.
3. Bredenbeek, P.J., Pachuck, C.J., Noten, A.F.H., Charité, J., Luytjes, W, Weiss, S.R., and Spaan, W.J.M., 1990, The primary structure and expression of the second open reading frame of the polymerase gene of the coronavirus MHV-A59; a highly conserved polymerase is expressed by an efficient ribosomal frameshifting mechanism, Nucleic Acids Res. 18:1825-1832.
4. Budzilowicz, C. J., Wilczynski, S. P., and Weiss, S. R., 1985, Three intergenic regions of coronavirus mouse hepatitis virus strain A59 contain a common nucleotide sequence that is homologous to the 3' end of the viral mRNA leader sequence, J. Virol. 53: 834-840.
5. Dalziel, R. G., Lampert, P. W., Talbot, P. J., and Buchmeier, M. J., 1986. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence, J. Virol. 59:463-471.
6. Fazakerley, J. K., Parker, S. E., Bloom, F., and Buchmeier, M. J., 1992, The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system, Virology 187: 178-188.
7. Fischer, F., Peng, D., Hingley, S. T., Weiss, S. R., and Masters, P. S., 1997, The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that it not essential for viral replication, J. Virol. 71: 996-1003.
8. Fleming, J. O., Trousdale, M. D., Bradbury, J., Stohlman, S. A., and Weiner, L. P., 1987, Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease, Microbial Pathogenesis 3: 9-20.
9. Fleming, J. O., Trousdale, M. D., El-Zaatari, F. A. K., Stohlman, S. A., and Weiner, L. P., 1986, Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies, J. Virol. 58: 869-875.
10. Gombold, J. L., Hingley, S. T., and Weiss, S. R., 1993, Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal, J. Virol. 67: 4504-4512.
11. Gombold, J. L., Sutherland, R. M., Lavi, E., Paterson, Y., and Weiss, S. R., 1995, Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells. Microbial Pathogenesis 18: 211-221.
12. Hingley, S. T., Gombold, J. L., Lavi, E., and Weiss, S. R., 1994, MHV-A59 fusion mutants are attenuated and display altered hepatotropism, Virology 200: 1-10.
13. Houtman, J. J., and Fleming, J. O., 1996, Pathogenesis of mouse hepatitis virus-induced demyelination, J. Neurovirol. 2: 361-376.
14. Kubo, H., Yamada, Y. K., and Taguchi, F., 1994, Localization of neutralizing epitopes and the receptor binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein, J. Virol. 68: 5404-5410.
15. Lavi, E., Gilden, D. H., Highkin, M. K., and Weiss, S. R., 1984, Persistence of MHV-A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization, J. Virol. 51: 563-566.
16. Lee, H. J., Shieh, C. K., Gorbalenya, A. E., Koonin, E. V., LaMonica, N., Tuler, J., Bagdzhadzhyan, A., and Lai, M. M. C., 1991, The complete sequence of the murine coronavirus gene 1 encoding the putative protease and RNA polymerase, Virology 180: 567-582.
17. Luytjes, W., Bredenbeek, P. J., Noten, A. F., Horzinek, M. C., and Spaan, W. J. M., 1988, Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus, Virology 166: 415-422.